OPGEN

opgen-logo

Headquartered in Rockville, Maryland, OpGen (NASDAQ:OPGN) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop and commercialize molecular microbiology solutions to help guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes. Our innovative approaches to infectious disease diagno... stics consist of highly multiplexed syndromic molecular panels, and next-generation sequencing combined with smart bioinformatics and artificial intelligence to address the global threat of antimicrobial resistance (AMR). By integrating these capabilities, we provide unique rapid molecular diagnostic products and services that help to dramatically transform patient care by using precision medicine to guide antibiotic therapy selection and optimize the treatment of life-threatening drug-resistant infections, improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms (MDROs). OpGen Community (Linkedin Group) provides an accessible environment to share information, exchange questions and best practices using OpGenโ€™s technologies in a variety of applications.

#SimilarOrganizations #People #Financial #Event #Website #More

OPGEN

Industry:
Biotechnology Genetics Health Care

Founded:
2002-01-01

Address:
Rockville, Maryland, United States

Country:
United States

Website Url:
http://www.opgen.com

Total Employee:
101+

Status:
Active

Contact:
+3018699683

Email Addresses:
[email protected]

Total Funding:
158.73 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

color-logo

Color

Color is a complete platform for healthcare delivery.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system


Current Advisors List

prabhavathi-fernandes_image

Prabhavathi Fernandes Director @ OpGen
Board_member

mario-crovetto_image

Mario Crovetto Director @ OpGen
Board_member

r-don-elsey_image

R Don Elsey Director @ OpGen
Board_member

william-rhodes_image

William Rhodes Chairman Of The Board @ OpGen
Board_member
2019-04-01

Current Employees Featured

oliver-schacht_image

Oliver Schacht
Oliver Schacht President and CEO @ OpGen
President and CEO
2020-04-01

johannes-bacher_image

Johannes Bacher
Johannes Bacher Chief Operating Officer @ OpGen
Chief Operating Officer

oliver-schacht_image

Oliver Schacht
Oliver Schacht CEO @ OpGen
CEO
2021-01-01

albert-weber_image

Albert Weber
Albert Weber Chief Financial Officer @ OpGen
Chief Financial Officer
2021-01-01

faranak-atrzadeh_image

Faranak Atrzadeh
Faranak Atrzadeh Chief Marketing and Scientific Affairs Officer @ OpGen
Chief Marketing and Scientific Affairs Officer

albert-risdorfer_image

Albert Risdorfer
Albert Risdorfer Sr Director Human Resources @ OpGen
Sr Director Human Resources
2015-12-01

Founder


not_available_image

David Schwartz

Stock Details


Company's stock symbol is NASDAQ:OPGN

Acquisitions List

Date Company Article Price
2015-07-14 AdvanDx AdvanDx acquired by OpGen N/A

Investors List

merck-global-health-innovation-fund_image

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund investment in Post-IPO Equity - OpGen

sabby-management_image

Sabby Management

Sabby Management investment in Post-IPO Equity - OpGen

merck-global-health-innovation-fund_image

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund investment in Post-IPO Equity - OpGen

180-degree-capital_image

180 Degree Capital

180 Degree Capital investment in Series C - OpGen

chl-medical-partners_image

CHL Medical Partners

CHL Medical Partners investment in Series C - OpGen

jven-capital_image

jVen Capital

jVen Capital investment in Series C - OpGen

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series C - OpGen

highland-capital-partners_image

Highland Capital Partners

Highland Capital Partners investment in Series C - OpGen

cross-creek-capital_image

Cross Creek

Cross Creek investment in Series C - OpGen

mason-wellsbiomediacl-fund_image

Mason Wells

Mason Wells investment in Series B - OpGen

Investments List

Date Company Article Money raised
2012-03-22 BioRelix OpGen investment in Venture Round - BioRelix 2.56 M USD

Key Employee Changes

Date New article
2021-11-04 OpGen Appoints Albert Weber as Chief Financial Officer

Official Site Inspections

http://www.opgen.com Semrush global rank: 4.52 M Semrush visits lastest month: 2.35 K

  • Host name: 49.122.212.35.bc.googleusercontent.com
  • IP address: 35.212.122.49
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "OpGen" on Search Engine